ELTX
Elicio Therapeutics Inc.
1.90$
+1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | |
| 50.3% | 48.2% | 9.4% | 76.4% | 63.1% | 4.4% | – | – | – | – | |
| 49.7% | 51.8% | 90.6% | 23.6% | 36.9% | 95.6% | – | – | – | – | |
| – | 3.0% | 227.1% | 2,003.2% | 1,350.0% | 171.7% | – | – | – | – | |
| – | – | – | 188.2% | 104.2% | 26.6% | – | – | – | – | |
| 55.4% | 57.8% | 446.5% | 2,618.8% | 1,956.1% | 234.5% | – | – | – | – | |
| -5.7% | -6.0% | -356.0% | -2,595.2% | -1,919.2% | -138.8% | – | – | – | – | |
| 4.2% | 4.6% | – | – | 307.2% | 3.1% | – | – | – | – | |
| 16.4% | 26.3% | -497.0% | -2,734.2% | -2,781.5% | -192.8% | – | – | – | – | |
| 2.8% | 6.9% | – | 5.5% | 0.3% | 3.1% | – | – | – | – | |
| 4.2% | 9.6% | -497.0% | -2,734.2% | -2,781.5% | -93.2% | – | – | – | – | |
| 26.9% | 1.0% | -355.9% | -2,700.9% | -2,452.5% | -183.4% | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.